Netripples Software FY26 Results: Net profit rises 29% to ₹2.72 lakh
- Net profit rose 29% YoY to ₹2.72 lakh; revenue grew 14% to ₹7.18 crore
- Operating cash flow turned negative at -₹6.71 lakh due to inventory buildup
- Cash reserves fell sharply to ₹46,001 from ₹4.77 lakh in the prior year
- Company remains debt-free with total reserves exceeding ₹3.12 crore
- BSE trading suspension revocation cited as top strategic priority

*this image is generated using AI for illustrative purposes only.
Netripples Software Limited reported a 29% year-on-year increase in net profit to ₹2,72,211 for FY26, driven by a 14% revenue growth to ₹7.18 crore. The Hyderabad-based IT services firm remains debt-free with reserves crossing ₹3 crore.
The company’s total income rose from ₹6.27 crore in FY25 to ₹7.18 crore in FY26. This growth occurred despite management citing challenges from the "onslaught of Artificial Intelligence" disrupting traditional business models. The Board highlighted sustained business continuity through long-term client relationships and expansion into healthcare e-commerce.
Financial Performance
Revenue from operations grew by ₹90.68 lakh compared to the previous fiscal year. While top-line growth was steady, other expenses increased significantly, rising from ₹6.65 crore in FY25 to ₹7.57 crore in FY26. Employee benefits expense also saw a modest increase to ₹13.14 lakh.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | ₹7,17,64,619 | ₹6,26,96,200 | +14.4% |
| Net Profit | ₹2,72,211 | ₹2,10,090 | +29.6% |
| Total Assets | ₹10,23,15,369 | ₹10,20,18,408 | +0.3% |
What the Numbers Show
Operating cash flow turned negative at -₹6.71 lakh in FY26, a sharp reversal from the positive ₹2.32 lakh generated in FY25. This deterioration coincided with an increase in inventory holdings, which rose by ₹55,419 during the year. The cash burn resulted in cash and cash equivalents dropping sharply from ₹4.77 lakh to just ₹46,001 as of March 31, 2026.
Corporate Governance & Outlook
Netripples’ shares remain under temporary suspension on the Bombay Stock Exchange. The Directors' Report identifies the revocation of this trading suspension as the foremost strategic priority for the coming year. The company has taken corrective measures to ensure timely submission of results in revised SEBI formats.
The firm continues to diversify beyond traditional IT services, maintaining an active e-commerce portfolio of over 75 healthcare packaged products for the SME segment. No dividend was declared for the year, and earnings per share stood at ₹0.04.
What specific compliance milestones must Netripples achieve to secure the lifting of its BSE trading suspension?
How will the company address the sharp decline in cash reserves and negative operating cash flow in the upcoming fiscal year?
To what extent is the new healthcare e-commerce segment expected to offset the revenue pressure from AI disruption in traditional IT services?

































